BIOG — Biotech Growth Trust Cashflow Statement
0.000.00%
Last trade - 00:00
FinancialsBalancedSmall Cap
- £311.77m
- £320.07m
- -£36.18m
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 21.3 | 61.1 | 201 | -202 | -41.2 |
Non-Cash Items | -24.6 | -64.1 | -224 | 209 | 35.5 |
Other Non-Cash Items | |||||
Changes in Working Capital | -1.09 | -0.798 | 18.1 | -18.4 | -0.144 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -4.4 | -3.77 | -5.67 | -12.1 | -5.89 |
Other Investing Cash Flow Items | 45.8 | 90.9 | -25.5 | 13 | 45.7 |
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 45.8 | 90.9 | -25.5 | 13 | 45.7 |
Financing Cash Flow Items | — | — | -0.25 | -0.179 | -0.792 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -41.4 | -87.2 | 32.7 | -2.39 | -37 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0 | 0 | 1.5 | -1.5 | 2.77 |